Another day, another record for the S&P 500. t didn't take too much for the Dow Industrials to also hit its highest level ever. The tech-heavy Nasdaq gained the most.
There's a powerful collection of 'what's working.'
By Jeff Brown
Yes, you might need nursing-home care. But the most common figures about those needs don't tell the whole story.
U.S. stock futures slip but Tokyo shares snap back; Home Depot's earnings top forecasts; SunEdison is buying a wind power company; Senate vote is scheduled on Keystone pipeline.
Actavis is finalizing a $66 billion deal to buy Botox-maker Allergan for a combination of cash and stock.
From Keystone to pharmaceuticals, industrials and energy, the Republican wins in midterm elections create real opportunities investors can take advantage of.
Stocks are little changed in midday trading Monday after opening slightly lower on Japan slipping into recession.
Here's how the president twists facts, economics and law to suit his policy agenda.
Pfizer is set to pay Merck $850 million for the rights to a new cancer drug.
U.S. stock futures fall as data shows Japan slips back into a recession; Actavis nears a deal to acquire Allergan, reports say; Halliburton and Baker Hughes reach merger deal.
The new migalastat data compliment earlier esults from successful phase III study announced in August by Amicus.
Positive data presented Friday, particularly the statistically significant survival benefit favoring patients treated with rindopepimut, has Celldex planning -- cautiously -- for a conversation with the FDA about accelerated approval.
U.S. stock futures rise ahead of retail sales data; Baker Hughes confirms it's in merger talks with Halliburton; Virgin America to begin trading Friday; Applied Materials meets earnings estimates.
Biotech columnist Adam Feuerstein answers readers' questions about health care.
Open enrollment for Obamacare began November 15th and will run until February 15th, 2015.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV